Abstract: Polypharmacy is a common means of clinical treatments, but detecting drug-drug interactions (DDIs) behind unexpected effects can be costly and faces clinical limitations. Recently, graph ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback